Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
Cha, Danielle S; Best, Michael W; Bowie, Christopher R; Gallaugher, Laura Ashley; Woldeyohannes, Hanna O; Soczynska, Joanna K; Lewis, Gary; MacQueen, Glenda; Sahakian, Barbara J; Kennedy, Sidney H; Lui, Jane P; Mansur, Rodrigo B; McIntyre, Roger S.
Affiliation
  • Cha DS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Best MW; Cognitive and Psychotic Disorders Lab, Department of Psychology, Queen's University, Kingston, ON, Canada.
  • Bowie CR; Director of Clinical Training, Department of Psychology, Queen's University, Kingston, ON, Canada; Clinician Scientist, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Gallaugher LA; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Woldeyohannes HO; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Soczynska JK; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Lewis G; Department of Endocrinology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
  • MacQueen G; Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
  • Sahakian BJ; London Imperial Affiliated Professor, University of Cambridge, United Kingdom.
  • Kennedy SH; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Lui JP; Pharmacist, Investigational Pharmacy Services, University Health Network, Toronto Western Hospital, Toronto, ON, Canada.
  • Mansur RB; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), Brazil.
  • McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: roger.mcintyre@uhn.on.ca.
J Affect Disord ; 210: 57-65, 2017 Mar 01.
Article in En | MEDLINE | ID: mdl-28013123
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognition / Affect / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant / Insulin Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Affect Disord Year: 2017 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognition / Affect / Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant / Insulin Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Affect Disord Year: 2017 Type: Article Affiliation country: Canada